Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.07, $0.08 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $114.4 million versus the consensus estimate of $100.27 million.

GUIDANCE:

Veracyte sees FY2024 revenue of $432-438 million, versus the consensus of $406.3 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.